[
  {
    "ts": null,
    "headline": "UBS Maintains Johnson & Johnson (JNJ) Buy Recommendation",
    "summary": "UBS Maintains Johnson & Johnson (JNJ) Buy Recommendation",
    "url": "https://finnhub.io/api/news?id=9531e00031278f22a780ee846552d6f7685e659ce4e678e98257a62585132c29",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760481909,
      "headline": "UBS Maintains Johnson & Johnson (JNJ) Buy Recommendation",
      "id": 137089452,
      "image": "",
      "related": "JNJ",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=9531e00031278f22a780ee846552d6f7685e659ce4e678e98257a62585132c29"
    }
  },
  {
    "ts": null,
    "headline": "J&J (JNJ) Earnings Growth Surges 70%—Reinforces Bullish Narratives on Profit Margin Strength",
    "summary": "Johnson & Johnson (JNJ) posted earnings growth of 70.2% for the most recent year, soaring past a solid 3.6% annual average over the last five years. The company’s net profit margin climbed to 27.3% from 16.8% a year ago, indicating a substantial boost in profitability. Although revenue is forecast to rise at 4.6% per year for the next three years, which is a slower pace than the US market’s expected 10%, JNJ continues to draw attention from investors for its resilient earnings quality and...",
    "url": "https://finnhub.io/api/news?id=ca0e4a12d8054b7e39033e1c8210f9232472d4a5b58ba077eb9e603dc109d06a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760479848,
      "headline": "J&J (JNJ) Earnings Growth Surges 70%—Reinforces Bullish Narratives on Profit Margin Strength",
      "id": 137093899,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (JNJ) posted earnings growth of 70.2% for the most recent year, soaring past a solid 3.6% annual average over the last five years. The company’s net profit margin climbed to 27.3% from 16.8% a year ago, indicating a substantial boost in profitability. Although revenue is forecast to rise at 4.6% per year for the next three years, which is a slower pace than the US market’s expected 10%, JNJ continues to draw attention from investors for its resilient earnings quality and...",
      "url": "https://finnhub.io/api/news?id=ca0e4a12d8054b7e39033e1c8210f9232472d4a5b58ba077eb9e603dc109d06a"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Moved the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More",
    "summary": "JPMorgan Chase, Wells Fargo, and Goldman Sachs post quarterly earnings that top Wall Street estimates.",
    "url": "https://finnhub.io/api/news?id=b55faaa9e4c06da13f373ceefba17cb850df467b4819380c6d34d1ed6aa93831",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760475960,
      "headline": "These Stocks Moved the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More",
      "id": 137089672,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "JPMorgan Chase, Wells Fargo, and Goldman Sachs post quarterly earnings that top Wall Street estimates.",
      "url": "https://finnhub.io/api/news?id=b55faaa9e4c06da13f373ceefba17cb850df467b4819380c6d34d1ed6aa93831"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to Watch Tuesday Recap: Walmart, J&J, AMD, Oracle",
    "summary": "↗️ Walmart (WMT): Shares of the retailer advanced 5% after it said it is forming a partnership with OpenAI to let shoppers buy its products directly within ChatGPT. ? Johnson & Johnson (JNJ): The healthcare giant said it planned to split off its orthopedics unit within two years and raised its annual sales outlook.",
    "url": "https://finnhub.io/api/news?id=bedb8937486060e213437bb4cbd1356dbe4d1a898d3c56d2a1f2f3bb363d559b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760474550,
      "headline": "Stocks to Watch Tuesday Recap: Walmart, J&J, AMD, Oracle",
      "id": 137093901,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "↗️ Walmart (WMT): Shares of the retailer advanced 5% after it said it is forming a partnership with OpenAI to let shoppers buy its products directly within ChatGPT. ? Johnson & Johnson (JNJ): The healthcare giant said it planned to split off its orthopedics unit within two years and raised its annual sales outlook.",
      "url": "https://finnhub.io/api/news?id=bedb8937486060e213437bb4cbd1356dbe4d1a898d3c56d2a1f2f3bb363d559b"
    }
  },
  {
    "ts": null,
    "headline": "S&P Drug Titan J&J Announces Its Surprise Spinoff Plans",
    "summary": "Johnson & Johnson said Tuesday it will spin off its orthopedics business into a new company called DePuy Synthes.",
    "url": "https://finnhub.io/api/news?id=8c47e396596253c0e2fe7ebea4b174767bf4ec434bc055fa432267314bc2b409",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760472803,
      "headline": "S&P Drug Titan J&J Announces Its Surprise Spinoff Plans",
      "id": 137093902,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson said Tuesday it will spin off its orthopedics business into a new company called DePuy Synthes.",
      "url": "https://finnhub.io/api/news?id=8c47e396596253c0e2fe7ebea4b174767bf4ec434bc055fa432267314bc2b409"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Higher Late Afternoon",
    "summary": "Health care stocks advanced late Tuesday afternoon, with the NYSE Health Care Index up 0.2% and the",
    "url": "https://finnhub.io/api/news?id=2f44c093dc9a283d60eef13e9d2ad181121fef8653e6ff23d7cd0cd1686efb3e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760471994,
      "headline": "Sector Update: Health Care Stocks Higher Late Afternoon",
      "id": 137087299,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Health care stocks advanced late Tuesday afternoon, with the NYSE Health Care Index up 0.2% and the",
      "url": "https://finnhub.io/api/news?id=2f44c093dc9a283d60eef13e9d2ad181121fef8653e6ff23d7cd0cd1686efb3e"
    }
  },
  {
    "ts": null,
    "headline": "Are Johnson & Johnson Shares Still a Good Value After Recent 32.6% Rally in 2025?",
    "summary": "Thinking about what to do with your Johnson & Johnson shares? You’re definitely not alone. Whether you already own the stock or are just considering a buy, there’s a lot to like about the way J&J has been moving lately. The company’s stock closed recently at $190.9 and has seen a nice upward trend, up 1.5% over the last week, 7.2% over the past month, and an impressive 32.6% year-to-date. That kind of momentum gets a lot of attention, especially given the steady 21.9% gain over the last year...",
    "url": "https://finnhub.io/api/news?id=c7b1e61aab52e40a24314371f8e9fc5886a6b81ac99263472c011702f8c344b8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760468780,
      "headline": "Are Johnson & Johnson Shares Still a Good Value After Recent 32.6% Rally in 2025?",
      "id": 137085552,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Thinking about what to do with your Johnson & Johnson shares? You’re definitely not alone. Whether you already own the stock or are just considering a buy, there’s a lot to like about the way J&J has been moving lately. The company’s stock closed recently at $190.9 and has seen a nice upward trend, up 1.5% over the last week, 7.2% over the past month, and an impressive 32.6% year-to-date. That kind of momentum gets a lot of attention, especially given the steady 21.9% gain over the last year...",
      "url": "https://finnhub.io/api/news?id=c7b1e61aab52e40a24314371f8e9fc5886a6b81ac99263472c011702f8c344b8"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Q3 2025 Earnings Call Highlights: Strong Growth in Innovative ...",
    "summary": "Johnson & Johnson (JNJ) reports robust sales growth and strategic moves to focus on high-growth areas despite challenges.",
    "url": "https://finnhub.io/api/news?id=177091fb3578431e9818287573afe0fb924fa6ebbd8fffb25b62441ed2acb9ec",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760468491,
      "headline": "Johnson & Johnson (JNJ) Q3 2025 Earnings Call Highlights: Strong Growth in Innovative ...",
      "id": 137085553,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (JNJ) reports robust sales growth and strategic moves to focus on high-growth areas despite challenges.",
      "url": "https://finnhub.io/api/news?id=177091fb3578431e9818287573afe0fb924fa6ebbd8fffb25b62441ed2acb9ec"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Are Moving the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More",
    "summary": "JPMorgan Chase, Wells Fargo, and Goldman Sachs post quarterly earnings that top Wall Street estimates.",
    "url": "https://finnhub.io/api/news?id=d9f0ae9235825ce8865ef600c4014f989f2f9652587912a0c7b13f6a219a8825",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760467560,
      "headline": "These Stocks Are Moving the Most Today: JPMorgan, Wells Fargo, Goldman, AMD, Walmart, J&J, Navitas, Polaris, and More",
      "id": 137085486,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "JPMorgan Chase, Wells Fargo, and Goldman Sachs post quarterly earnings that top Wall Street estimates.",
      "url": "https://finnhub.io/api/news?id=d9f0ae9235825ce8865ef600c4014f989f2f9652587912a0c7b13f6a219a8825"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson’s (JNJ) Strong Dividend Track Record and Focus on Innovation",
    "summary": "Johnson & Johnson (NYSE:JNJ) is included among the 12 Reliable Dividend Stocks for Maximum Income. Johnson & Johnson (NYSE:JNJ) operates as a global healthcare lea‍de‌r, focusing p‌rimari​ly on pharmaceuticals and medi⁠cal d‍evices. Its⁠ operations are di‍vided into two main se⁠gment​s: Innovative Me⁠dicine, which de⁠velops and markets prescription drugs, and MedTech, which produces medi⁠cal d‌evic‌es. Up […]",
    "url": "https://finnhub.io/api/news?id=b79ea772c3b442c0d2b931c5944941550fccf92c774cabe83d8742a04d937629",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760467311,
      "headline": "Johnson & Johnson’s (JNJ) Strong Dividend Track Record and Focus on Innovation",
      "id": 137085555,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is included among the 12 Reliable Dividend Stocks for Maximum Income. Johnson & Johnson (NYSE:JNJ) operates as a global healthcare lea‍de‌r, focusing p‌rimari​ly on pharmaceuticals and medi⁠cal d‍evices. Its⁠ operations are di‍vided into two main se⁠gment​s: Innovative Me⁠dicine, which de⁠velops and markets prescription drugs, and MedTech, which produces medi⁠cal d‌evic‌es. Up […]",
      "url": "https://finnhub.io/api/news?id=b79ea772c3b442c0d2b931c5944941550fccf92c774cabe83d8742a04d937629"
    }
  },
  {
    "ts": null,
    "headline": "Fed Chair's Remarks, Trade Developments Leave Equities Mixed Intraday",
    "summary": "US benchmark equity indexes were mixed intraday as traders parsed comments by Federal Reserve Chair",
    "url": "https://finnhub.io/api/news?id=5b616f1a939fd0610647238e629213c6224291927f80e41526121c3e3f6ec712",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760466306,
      "headline": "Fed Chair's Remarks, Trade Developments Leave Equities Mixed Intraday",
      "id": 137085490,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "US benchmark equity indexes were mixed intraday as traders parsed comments by Federal Reserve Chair",
      "url": "https://finnhub.io/api/news?id=5b616f1a939fd0610647238e629213c6224291927f80e41526121c3e3f6ec712"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to Watch Tuesday: Walmart, J&J, AMD, Oracle",
    "summary": "↗️ Walmart (WMT): Shares of the retailer advanced 5% after it said it is forming a partnership with OpenAI to let shoppers buy its products directly within ChatGPT. ? Johnson & Johnson (JNJ): The healthcare giant said it planned to split off its orthopedics unit within two years and raised its annual sales outlook.",
    "url": "https://finnhub.io/api/news?id=23f56074870cac3f357b4f7925b0b304362814d8e96ad13d34049b1f72f45f7a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760465982,
      "headline": "Stocks to Watch Tuesday: Walmart, J&J, AMD, Oracle",
      "id": 137085526,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "↗️ Walmart (WMT): Shares of the retailer advanced 5% after it said it is forming a partnership with OpenAI to let shoppers buy its products directly within ChatGPT. ? Johnson & Johnson (JNJ): The healthcare giant said it planned to split off its orthopedics unit within two years and raised its annual sales outlook.",
      "url": "https://finnhub.io/api/news?id=23f56074870cac3f357b4f7925b0b304362814d8e96ad13d34049b1f72f45f7a"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Higher Tuesday Afternoon",
    "summary": "Health care stocks edged higher Tuesday afternoon, with the NYSE Health Care Index and the Health Ca",
    "url": "https://finnhub.io/api/news?id=983ed27b3faedc31205ecceedc7dbc2bf60c4e5bcda89ba07a35221f8997ad9b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760463771,
      "headline": "Sector Update: Health Care Stocks Higher Tuesday Afternoon",
      "id": 137085558,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Health care stocks edged higher Tuesday afternoon, with the NYSE Health Care Index and the Health Ca",
      "url": "https://finnhub.io/api/news?id=983ed27b3faedc31205ecceedc7dbc2bf60c4e5bcda89ba07a35221f8997ad9b"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer Believes Johnson & Johnson’s Earnings Should Be the Strongest Among Pharmaceuticals",
    "summary": "Johnson & Johnson (NYSE:JNJ) is one of the stocks in Jim Cramer’s game plan for this week. Cramer expects the most from JNJ out of all the companies in the pharmaceutical industry, as he commented: “Beyond the banks, we hear from Johnson & Johnson, which should have the strongest numbers of any pharmaceutical company. The […]",
    "url": "https://finnhub.io/api/news?id=7a5de8bf9b6b2b0b9726806b70d94329fb13e464b608053464be7db7835a4721",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760462516,
      "headline": "Jim Cramer Believes Johnson & Johnson’s Earnings Should Be the Strongest Among Pharmaceuticals",
      "id": 137085559,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is one of the stocks in Jim Cramer’s game plan for this week. Cramer expects the most from JNJ out of all the companies in the pharmaceutical industry, as he commented: “Beyond the banks, we hear from Johnson & Johnson, which should have the strongest numbers of any pharmaceutical company. The […]",
      "url": "https://finnhub.io/api/news?id=7a5de8bf9b6b2b0b9726806b70d94329fb13e464b608053464be7db7835a4721"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Roundup: Market Talk",
    "summary": "Health Care Roundup: Market Talk",
    "url": "https://finnhub.io/api/news?id=2576ac775f19f55b795459fc6a4cfb92e71295dbd63f9d0fc53c60ec9cb8a643",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760461800,
      "headline": "Health Care Roundup: Market Talk",
      "id": 137108394,
      "image": "",
      "related": "JNJ",
      "source": "DowJones",
      "summary": "Health Care Roundup: Market Talk",
      "url": "https://finnhub.io/api/news?id=2576ac775f19f55b795459fc6a4cfb92e71295dbd63f9d0fc53c60ec9cb8a643"
    }
  },
  {
    "ts": null,
    "headline": "J&J spins off orthopaedics business against positive Q3 backdrop",
    "summary": "The orthopaedic separation announcement arrived hot on the heels of positive Q3 financial results.",
    "url": "https://finnhub.io/api/news?id=f2a3126a6015995fbd256e6c64ce75e41371bd3525f98da30fdc84ba5aaba684",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760461677,
      "headline": "J&J spins off orthopaedics business against positive Q3 backdrop",
      "id": 137085560,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The orthopaedic separation announcement arrived hot on the heels of positive Q3 financial results.",
      "url": "https://finnhub.io/api/news?id=f2a3126a6015995fbd256e6c64ce75e41371bd3525f98da30fdc84ba5aaba684"
    }
  },
  {
    "ts": null,
    "headline": "J&J stock falls on earnings: Why this analyst is still bullish",
    "summary": "Johnson & Johnson (JNJ) stock is in focus after the company reported earnings and announced a spin-off of its orthopedics business. Guggenheim Securities senior research analyst and managing director Vamil Divan joins Market Catalysts to examine the earnings print, discuss what's driving the stock lower, and outline his bullish case for the stock. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
    "url": "https://finnhub.io/api/news?id=05e1df074dfe8c87d3d525dc46b138638ffcd9595f96deea337d800e77858bdf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760457769,
      "headline": "J&J stock falls on earnings: Why this analyst is still bullish",
      "id": 137085562,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (JNJ) stock is in focus after the company reported earnings and announced a spin-off of its orthopedics business. Guggenheim Securities senior research analyst and managing director Vamil Divan joins Market Catalysts to examine the earnings print, discuss what's driving the stock lower, and outline his bullish case for the stock. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
      "url": "https://finnhub.io/api/news?id=05e1df074dfe8c87d3d525dc46b138638ffcd9595f96deea337d800e77858bdf"
    }
  },
  {
    "ts": null,
    "headline": "JNJ Beats on Q3 Earnings, Ups Sales View, to Spin-off Orthopaedics Unit",
    "summary": "J&J tops Q3 forecasts, lifts 2025 sales outlook and plans to spin off its struggling Orthopaedics business.",
    "url": "https://finnhub.io/api/news?id=7e6d8cbabed991bef626fd4080767c62a4a5039bfdc695687131129868ad6627",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760457600,
      "headline": "JNJ Beats on Q3 Earnings, Ups Sales View, to Spin-off Orthopaedics Unit",
      "id": 137085563,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "J&J tops Q3 forecasts, lifts 2025 sales outlook and plans to spin off its struggling Orthopaedics business.",
      "url": "https://finnhub.io/api/news?id=7e6d8cbabed991bef626fd4080767c62a4a5039bfdc695687131129868ad6627"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?",
    "summary": "Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",
    "url": "https://finnhub.io/api/news?id=a1f8a7b5d31de4841131ce05c655b6241dace3e724c97e7317ddea8c8d4bfd8c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760456705,
      "headline": "Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?",
      "id": 137085564,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.",
      "url": "https://finnhub.io/api/news?id=a1f8a7b5d31de4841131ce05c655b6241dace3e724c97e7317ddea8c8d4bfd8c"
    }
  },
  {
    "ts": null,
    "headline": "IGD: Trading Capital Appreciation For Income",
    "summary": "IGD underperforms major equity indices in price appreciation, but its high yield offsets declines when distributions are reinvested. Find out why IGD is a Hold.",
    "url": "https://finnhub.io/api/news?id=c48a0506bfd2802f07af36f5104e50b24e8c5f042ca86e2ea94e13fbc579b925",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760456520,
      "headline": "IGD: Trading Capital Appreciation For Income",
      "id": 137086456,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2213005313/image_2213005313.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "IGD underperforms major equity indices in price appreciation, but its high yield offsets declines when distributions are reinvested. Find out why IGD is a Hold.",
      "url": "https://finnhub.io/api/news?id=c48a0506bfd2802f07af36f5104e50b24e8c5f042ca86e2ea94e13fbc579b925"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Stock Moves Higher After Delivering Robust Q3 Growth",
    "summary": "Johnson & Johnson Impresses Wall Street With Q3 Beat And Confident 2025 Outlook",
    "url": "https://finnhub.io/api/news?id=6d7151d10a48d02c3f62b574139d14ba4f6f44f4eb0c1bf571f23a3196687721",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760456452,
      "headline": "Johnson & Johnson Stock Moves Higher After Delivering Robust Q3 Growth",
      "id": 137085565,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson Impresses Wall Street With Q3 Beat And Confident 2025 Outlook",
      "url": "https://finnhub.io/api/news?id=6d7151d10a48d02c3f62b574139d14ba4f6f44f4eb0c1bf571f23a3196687721"
    }
  },
  {
    "ts": null,
    "headline": "J&J CFO Wolk on Orthopedics Spinoff, Earnings, Drug Pricing",
    "summary": "Johnson & Johnson CFO Joe Wolk says the company is well positioned for a strong 2026 and discusses plans to spin off its slower-growing orthopedics business and the outlook for drug pricing on \"Bloomberg Open Interest.\" J&J announced third-quarter sales and earnings that modestly beat expectations, and raised revenue guidance for the full year.",
    "url": "https://finnhub.io/api/news?id=2596815abe86678e63c6fb04379bb0ff3852867515140daef807d7cda2efe281",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760456146,
      "headline": "J&J CFO Wolk on Orthopedics Spinoff, Earnings, Drug Pricing",
      "id": 137085566,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson CFO Joe Wolk says the company is well positioned for a strong 2026 and discusses plans to spin off its slower-growing orthopedics business and the outlook for drug pricing on \"Bloomberg Open Interest.\" J&J announced third-quarter sales and earnings that modestly beat expectations, and raised revenue guidance for the full year.",
      "url": "https://finnhub.io/api/news?id=2596815abe86678e63c6fb04379bb0ff3852867515140daef807d7cda2efe281"
    }
  },
  {
    "ts": null,
    "headline": "Top Midday Stories: Big Banks Kick Off Earnings Season; Johnson & Johnson to Spin Off Orthopedics Business",
    "summary": "JPMorgan Chase (JPM) reported Q3 earnings Tuesday of $5.07 per diluted share, up from $4.37 a year e",
    "url": "https://finnhub.io/api/news?id=f325245e709fba1735e9300b21ea4ad9cbc489bca1563dcd228641a9c666adad",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760455883,
      "headline": "Top Midday Stories: Big Banks Kick Off Earnings Season; Johnson & Johnson to Spin Off Orthopedics Business",
      "id": 137085567,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "JPMorgan Chase (JPM) reported Q3 earnings Tuesday of $5.07 per diluted share, up from $4.37 a year e",
      "url": "https://finnhub.io/api/news?id=f325245e709fba1735e9300b21ea4ad9cbc489bca1563dcd228641a9c666adad"
    }
  },
  {
    "ts": null,
    "headline": "NFIB Small-Business Optimism Index Drops in September",
    "summary": "NFIB Small-Business Optimism Index Drops in September.",
    "url": "https://finnhub.io/api/news?id=0485d2812c86fc5441aa3dd20d21d77ada528d04198cacabbe3651a339551cd9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760454600,
      "headline": "NFIB Small-Business Optimism Index Drops in September",
      "id": 137085568,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "NFIB Small-Business Optimism Index Drops in September.",
      "url": "https://finnhub.io/api/news?id=0485d2812c86fc5441aa3dd20d21d77ada528d04198cacabbe3651a339551cd9"
    }
  },
  {
    "ts": null,
    "headline": "Can Rinvoq and Skyrizi Sales Drive Another Strong Quarter for AbbVie?",
    "summary": "ABBV leans on booming Skyrizi and Rinvoq-driven sales to sustain growth and counter Humira's decline as Q3 results approach.",
    "url": "https://finnhub.io/api/news?id=6a8b7af46b3d6cfb0ab5527d9dc920b0d4a2f26f7e6667e176ab5929df99e608",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760454540,
      "headline": "Can Rinvoq and Skyrizi Sales Drive Another Strong Quarter for AbbVie?",
      "id": 137085506,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "ABBV leans on booming Skyrizi and Rinvoq-driven sales to sustain growth and counter Humira's decline as Q3 results approach.",
      "url": "https://finnhub.io/api/news?id=6a8b7af46b3d6cfb0ab5527d9dc920b0d4a2f26f7e6667e176ab5929df99e608"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Lifts Sales Outlook Following Quarterly Beat, Plans Orthopaedics Unit Spinoff",
    "summary": "Johnson & Johnson (JNJ) raised its full-year sales guidance on Tuesday following stronger-than-expec",
    "url": "https://finnhub.io/api/news?id=9d353f889486e1ae8c175c9f323d68df036ad5351b2924f7b7759aada4c864fb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760453017,
      "headline": "Johnson & Johnson Lifts Sales Outlook Following Quarterly Beat, Plans Orthopaedics Unit Spinoff",
      "id": 137085570,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (JNJ) raised its full-year sales guidance on Tuesday following stronger-than-expec",
      "url": "https://finnhub.io/api/news?id=9d353f889486e1ae8c175c9f323d68df036ad5351b2924f7b7759aada4c864fb"
    }
  },
  {
    "ts": null,
    "headline": "Pre-markets Volatile as Q3 Bank Earnings Come Out",
    "summary": "The market continues to work toward some equilibrium amid plenty of near-term challenges.",
    "url": "https://finnhub.io/api/news?id=3c7758ce96de49cc9ac54135ddb3be4e36052546ff98bcc15abafdd69897dcd4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760452200,
      "headline": "Pre-markets Volatile as Q3 Bank Earnings Come Out",
      "id": 137085571,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The market continues to work toward some equilibrium amid plenty of near-term challenges.",
      "url": "https://finnhub.io/api/news?id=3c7758ce96de49cc9ac54135ddb3be4e36052546ff98bcc15abafdd69897dcd4"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson 2025 Q3 - Results - Earnings Call Presentation",
    "summary": "2025-10-14. The following slide deck was published by Johnson & Johnson in conjunction with their 2025 Q3 earnings call.",
    "url": "https://finnhub.io/api/news?id=a750e26b1d7dd0cadb5d59be8fc03b79b8dfb9b1644d141ee68e9a02b65028b8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760445632,
      "headline": "Johnson & Johnson 2025 Q3 - Results - Earnings Call Presentation",
      "id": 137077235,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "2025-10-14. The following slide deck was published by Johnson & Johnson in conjunction with their 2025 Q3 earnings call.",
      "url": "https://finnhub.io/api/news?id=a750e26b1d7dd0cadb5d59be8fc03b79b8dfb9b1644d141ee68e9a02b65028b8"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Q3 2025 Earnings Call Transcript",
    "summary": "Johnson & Johnson (NYSE:JNJ) Q3 2025 Earnings Call October 14, 2025 8:30 AM EDTCompany ParticipantsDarren Snellgrove - Vice President of Investor...",
    "url": "https://finnhub.io/api/news?id=9b84aae626ee5f4e657e1dab1da5721faaa87d4a1a6ee18dde7d214d8d8b11d2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760445397,
      "headline": "Johnson & Johnson (JNJ) Q3 2025 Earnings Call Transcript",
      "id": 137077237,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Johnson & Johnson (NYSE:JNJ) Q3 2025 Earnings Call October 14, 2025 8:30 AM EDTCompany ParticipantsDarren Snellgrove - Vice President of Investor...",
      "url": "https://finnhub.io/api/news?id=9b84aae626ee5f4e657e1dab1da5721faaa87d4a1a6ee18dde7d214d8d8b11d2"
    }
  },
  {
    "ts": null,
    "headline": "J&J ups guidance as earnings climb, plans to spin off orthopaedics arm",
    "summary": "J&J ups guidance as earnings climb, plans to spin off orthopaedics arm",
    "url": "https://finnhub.io/api/news?id=f381b5cf9410cc212af3d8c45a9e8909da500598f582f79e0290cab1be91a3a1",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760440147,
      "headline": "J&J ups guidance as earnings climb, plans to spin off orthopaedics arm",
      "id": 137076136,
      "image": "",
      "related": "JNJ",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=f381b5cf9410cc212af3d8c45a9e8909da500598f582f79e0290cab1be91a3a1"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Lunch: Wall Street Giants Edge Out Q3 Earnings Expectations",
    "summary": "Big banks are kicking off earnings season with consensus-bearing results â as usual.",
    "url": "https://finnhub.io/api/news?id=07c49280f2d8da1b213a5d0a3b7d38f8f100be5b37bbc56fa85ad206f013afa1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760436900,
      "headline": "Wall Street Lunch: Wall Street Giants Edge Out Q3 Earnings Expectations",
      "id": 137076711,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/880121294/image_880121294.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Big banks are kicking off earnings season with consensus-bearing results â as usual.",
      "url": "https://finnhub.io/api/news?id=07c49280f2d8da1b213a5d0a3b7d38f8f100be5b37bbc56fa85ad206f013afa1"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Q3 Earnings Surprise, Icotrokinra Shines Again",
    "summary": "Johnson & Johnson's Q3 2025 earnings beat forecasts, with strong oncology sales and raised guidance. Click for my updated look at JNJ stock prospects.",
    "url": "https://finnhub.io/api/news?id=2d338e41d2ed5636b2c4f31ccf41db9670c3f47ddb04a5f8f264d19468c2cead",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760432295,
      "headline": "Johnson & Johnson Q3 Earnings Surprise, Icotrokinra Shines Again",
      "id": 137076426,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2212125573/image_2212125573.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Johnson & Johnson's Q3 2025 earnings beat forecasts, with strong oncology sales and raised guidance. Click for my updated look at JNJ stock prospects.",
      "url": "https://finnhub.io/api/news?id=2d338e41d2ed5636b2c4f31ccf41db9670c3f47ddb04a5f8f264d19468c2cead"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Earnings Beat Estimates. Why the Stock Is Dropping.",
    "summary": "Johnson & Johnson Earnings Beat Estimates. Why the Stock Is Dropping.",
    "url": "https://finnhub.io/api/news?id=b7127f7d3a60f837610926957f14b403a026e36b1f4c43969bc9230f08bb9803",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760431380,
      "headline": "Johnson & Johnson Earnings Beat Estimates. Why the Stock Is Dropping.",
      "id": 137110306,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Johnson & Johnson Earnings Beat Estimates. Why the Stock Is Dropping.",
      "url": "https://finnhub.io/api/news?id=b7127f7d3a60f837610926957f14b403a026e36b1f4c43969bc9230f08bb9803"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson’s stock heads for a record after a profit beat and plans for another spinoff",
    "summary": "Johnson & Johnson’s stock heads for a record after a profit beat and plans for another spinoff",
    "url": "https://finnhub.io/api/news?id=a3216370351a86412c496ec5b40c6b577eefe88bae75729c79703670d6ce0a88",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760427840,
      "headline": "Johnson & Johnson’s stock heads for a record after a profit beat and plans for another spinoff",
      "id": 137136655,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Johnson & Johnson’s stock heads for a record after a profit beat and plans for another spinoff",
      "url": "https://finnhub.io/api/news?id=a3216370351a86412c496ec5b40c6b577eefe88bae75729c79703670d6ce0a88"
    }
  },
  {
    "ts": null,
    "headline": "J&J Lifts Full-Year Sales Outlook, Fueled by Pharma, Med-Device Gains",
    "summary": "J&J Lifts Full-Year Sales Outlook, Fueled by Pharma, Med-Device Gains",
    "url": "https://finnhub.io/api/news?id=8a66b2a719f33f1eeb108f10cf03d02b7e8838eddc64276d6932d15e51dd549e",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760423520,
      "headline": "J&J Lifts Full-Year Sales Outlook, Fueled by Pharma, Med-Device Gains",
      "id": 137108396,
      "image": "",
      "related": "JNJ",
      "source": "DowJones",
      "summary": "J&J Lifts Full-Year Sales Outlook, Fueled by Pharma, Med-Device Gains",
      "url": "https://finnhub.io/api/news?id=8a66b2a719f33f1eeb108f10cf03d02b7e8838eddc64276d6932d15e51dd549e"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson to Split Off Orthopedics Business",
    "summary": "Johnson & Johnson to Split Off Orthopedics Business",
    "url": "https://finnhub.io/api/news?id=2ee23ce16d0c4717a87c0e265e112b66afd120ed7b3ece333dfc4ecc17cbff85",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760422800,
      "headline": "Johnson & Johnson to Split Off Orthopedics Business",
      "id": 137108397,
      "image": "",
      "related": "JNJ",
      "source": "DowJones",
      "summary": "Johnson & Johnson to Split Off Orthopedics Business",
      "url": "https://finnhub.io/api/news?id=2ee23ce16d0c4717a87c0e265e112b66afd120ed7b3ece333dfc4ecc17cbff85"
    }
  },
  {
    "ts": null,
    "headline": "JPMorgan, Citi and Goldman help kick off the the third quarter earnings season",
    "summary": "JPMorgan, Citi and Goldman help kick off the the third quarter earnings season",
    "url": "https://finnhub.io/api/news?id=9ccf29d08d42511e77977e4d8668de50db1d68ec47c320a134a2ebf01d9f44d3",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760420368,
      "headline": "JPMorgan, Citi and Goldman help kick off the the third quarter earnings season",
      "id": 137079050,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "JPMorgan, Citi and Goldman help kick off the the third quarter earnings season",
      "url": "https://finnhub.io/api/news?id=9ccf29d08d42511e77977e4d8668de50db1d68ec47c320a134a2ebf01d9f44d3"
    }
  }
]